Mardassi Ali, Turki Senda, Lahiani Rim, Mbarek Hajer, Benzarti Sonia, Gharsallah Hédi
Tunis Med. 2016 Dec;94(12):863.
Necrotizing otitis externa remains a severe and sometimes life-threatening disease in diabetic patient. Many therapeutic approaches have been described but what about the real benefit of hyperbaric oxygenotherapy in the management of this disease?
The authors reported a retrospective study about 42 patients treated for necrotizing external otitis over a period of 9 years (2006 to 2014). The patients were treated either by only antibiotherapy (23 cases) or with both antibiotherapy and hyperbaric oxygenotherapy (19 cases). The evolution under treatment was appreciated in the two groups through clinical, biological and radiological parameters.
The study included 42 diabetic patients with a mean age of 67 years (50 to 84 years). The sex-ratio M/F was 0.82. The diagnosis of necrotizing otitis externa was assessed through clinical and bacteriologic criteria in diabetic patients. A temporal bone CT-scan and a technetium scintigraphy were performed in order to precise the topography of the disease and the level of bone lysis. Antibiotherapy was prescribed intravenously and then orally for a mean period of 8 weeks (5 to 15 weeks). Hyperbaric oxygenotherapy was given for 19 patients (average: 20 sessions). The recovery was affirmed on clinical, biological and radiological features. Otalgia disappeared at the 11th day of treatment without HOT and at the 5th day with HOT. Otorrhea disappeared at the 6th day of treatment by HOT and at the 13th day without HOT. The recovery or the regression of facial palsy occurred in 75% of the cases when HOT was given. The total recovery from the disease was diagnosed in 36 patients (86%). The rate of recovery was 100% in the group treated by HOT and 74% in the group treated by only antibiotics. The recurrence of the disease was noted in 6 patients that haven't benefited from HOT. The end of the oral therapy was guided by the results of the Gallium bone scintigraphy.
Hyperbaric oxygenotherapy must be associated in the treatment of necrotizing otitis externa. The results of our study suggest a real benefit of this therapy regarding clinical, biological and radiological parameters of this severe affection.
坏死性外耳道炎在糖尿病患者中仍然是一种严重的、有时甚至危及生命的疾病。已经描述了许多治疗方法,但高压氧疗法在这种疾病的治疗中真正的益处如何呢?
作者报告了一项回顾性研究,该研究涉及42例在9年期间(2006年至2014年)接受坏死性外耳道炎治疗的患者。患者要么仅接受抗生素治疗(23例),要么同时接受抗生素治疗和高压氧疗法(19例)。通过临床、生物学和放射学参数评估两组患者在治疗过程中的病情演变。
该研究纳入了42例糖尿病患者,平均年龄67岁(50至84岁)。男女比例为0.82。通过糖尿病患者的临床和细菌学标准评估坏死性外耳道炎的诊断。进行颞骨CT扫描和镓闪烁扫描以明确疾病的部位和骨质溶解程度。静脉内然后口服抗生素治疗,平均疗程为8周(5至15周)。19例患者接受了高压氧疗法(平均:20次治疗)。根据临床、生物学和放射学特征确定病情恢复情况。未接受高压氧疗法时,耳痛在治疗第11天消失,接受高压氧疗法时在第5天消失。接受高压氧疗法时耳漏在治疗第6天消失,未接受高压氧疗法时在第13天消失。接受高压氧疗法时,75%的病例出现面瘫恢复或改善。36例患者(86%)被诊断为疾病完全康复。接受高压氧疗法组的康复率为100%,仅接受抗生素治疗组的康复率为74%。6例未接受高压氧疗法的患者出现疾病复发。口服治疗的结束以镓骨闪烁扫描结果为指导。
坏死性外耳道炎的治疗必须联合高压氧疗法。我们的研究结果表明,这种疗法在这种严重疾病的临床、生物学和放射学参数方面具有实际益处。